4-Methoxy-N-[2'-methyl-4'-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-yl]-3-(4-methyl-piperazin-1-yl)-benzamide

ID: ALA306384

PubChem CID: 10481003

Max Phase: Preclinical

Molecular Formula: C29H31N5O3

Molecular Weight: 497.60

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1

Standard InChI:  InChI=1S/C29H31N5O3/c1-19-17-22(28-30-20(2)37-32-28)7-11-25(19)21-5-9-24(10-6-21)31-29(35)23-8-12-27(36-4)26(18-23)34-15-13-33(3)14-16-34/h5-12,17-18H,13-16H2,1-4H3,(H,31,35)

Standard InChI Key:  BRWASLBCBODGKZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -0.2458   -3.5375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2417   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2500   -2.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5000   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9250   -2.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0333   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0333   -2.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2542   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7125   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3042   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0167   -2.8667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4792   -3.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7667   -0.7125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3042   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9125   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5375   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0125   -4.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5042   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7542   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4792   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -4.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5000   -4.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1917   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9500   -3.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9500   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9375   -0.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1792   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -3.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7375   -3.5792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1917   -0.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7167   -4.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000   -3.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1417   -4.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  8  2  0
  5  4  1  0
  6 14  1  0
  7  1  2  0
  8 10  1  0
  9  7  1  0
 10  6  1  0
 11  2  1  0
 12 17  2  0
 13 15  2  0
 14 26  1  0
 15 11  1  0
 16 30  1  0
 17 23  1  0
 18 25  2  0
 19 12  1  0
 20  6  2  0
 21  5  1  0
 22  5  1  0
 23 11  2  0
 24 10  2  0
 25 24  1  0
 26 32  1  0
 27 19  2  0
 28 19  1  0
 29 21  1  0
 30 22  1  0
 31 27  1  0
 32 28  2  0
 33 18  1  0
 34 16  1  0
 35 13  1  0
 36  7  1  0
 37 33  1  0
  9  3  1  0
 12 13  1  0
 26 31  2  0
 18  4  1  0
 29 16  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA306384

   4-methoxy-N-[4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]-3-(4-methylpiperazin-1-yl)benzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 497.60

Molecular Weight (Monoisotopic): 497.2427

AlogP: 5.03

#Rotatable Bonds: 6

Polar Surface Area: 83.73

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 7.34

CX LogP: 5.41

CX LogD: 5.14

Aromatic Rings: 4

Heavy Atoms: 37

QED Weighted: 0.40

Np Likeness Score: -1.62

References

1. Clitherow JW, Scopes DI, Skingle M, Jordan CC, Feniuk W, Campbell IB, Carter MC, Collington EW, Connor HE, Higgins GA..  (1994)  Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.,  37  (15): [PMID:8057272] [10.1021/jm00041a001]

Source

Source(1):

• Scientific Literature